Ordering
Available Variants50 mg
CHA.89400-50mg
Price
€430.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.89400-50mg | €430.40 |
≥98.0% (TLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C6H13NO3 |
|---|---|
| CAS Number | 55399-93-4 |
| Molecular Weight | 147.17 |
| UNSPSC Code | 12352209 |
| eCl@ss | 32160406 |
| PubChem Substance ID | 329757568 |
| NACRES | NA.26 |
| Beilstein/REAXYS Number | 4128096 |
| MDL number | MFCD07357252 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | 296.6 °F |
| flash_point_c | 147 °C |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
(4S)-4-Hydroxy-L-isoleucine, with the CAS number 55399-93-4, is a non-proteinogenic amino acid that has garnered significant attention in recent years due to its potential therapeutic applications. This compound is primarily found in the seeds of the Trigonella foenum-graecum plant, commonly known as fenugreek. Research has shown that (4S)-4-Hydroxy-L-isoleucine exhibits notable hypoglycemic properties, making it a potential candidate for the treatment of type 2 diabetes. Additionally, it has been found to stimulate insulin secretion and improve glucose metabolism, highlighting its potential as a therapeutic agent for the management of metabolic disorders. Further studies are necessary to fully elucidate the mechanisms of action and potential benefits of (4S)-4-Hydroxy-L-isoleucine, but its unique properties make it an interesting subject for ongoing research in the field of pharmacology and medicine.
